Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Financing Activities (2020 - 2025)

Bio Essence has reported Cash from Financing Activities over the past 6 years, most recently at -$1.3 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$1.3 million for Q4 2025, down 181.23% from a year ago — trailing twelve months through Dec 2025 was -$1.6 million (down 152.39% YoY), and the annual figure for FY2025 was -$1.6 million, down 152.39%.
  • Cash from Financing Activities for Q4 2025 was -$1.3 million at Bio Essence, down from -$158232.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BIOE hit a ceiling of $828847.0 in Q2 2021 and a floor of -$1.3 million in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was $181870.5 (2022), compared with a mean of $57986.6.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 226.5% in 2021 and later plummeted 2789.56% in 2025.
  • Bio Essence's Cash from Financing Activities stood at $206002.0 in 2021, then crashed by 31.8% to $140500.0 in 2022, then soared by 156.31% to $360117.0 in 2023, then crashed by 225.38% to -$451513.0 in 2024, then tumbled by 181.23% to -$1.3 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$1.3 million (Q4 2025), -$158232.0 (Q3 2025), and -$167797.0 (Q2 2025) per Business Quant data.